Incorporating Biomarker Stratification into STAMPEDE: an Adaptive Multi-arm, Multi-stage Trial Platform

The treatment and outcomes for advanced prostate cancer have experienced significant progress over recent years. Importantly, the additional benefits of ‘up front’ chemotherapy (docetaxel) and abiraterone, over and above conventional androgen deprivation, have been separately demonstrated in the mul...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilson, C., Chowdhury, S., Parmar, M.K.B., Sydes, M.R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: W.B. Saunders 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710986/
https://www.ncbi.nlm.nih.gov/pubmed/29079227
http://dx.doi.org/10.1016/j.clon.2017.10.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710986/
https://www.ncbi.nlm.nih.gov/pubmed/29079227
http://dx.doi.org/10.1016/j.clon.2017.10.004

Ejemplares similares